During the past decade, Universitätsklinikum Regensburg; Klinik und Poliklinik für Dermatologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 3 clinical trials were completed, i.e. on average, 300% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitätsklinikum Regensburg; Klinik und Poliklinik für Dermatologie" are "Basal Cell Carcinoma" (1 trials), "Malignant Melanoma" (1 trials) and "Melanoma" (1 trials). Many other conditions were trialed in "Universitätsklinikum Regensburg; Klinik und Poliklinik für Dermatologie" in a lesser frequency.

Most popular intervention types in "Universitätsklinikum Regensburg; Klinik und Poliklinik für Dermatologie" are "Drug" (3 trials). Other intervention types were less common.

The name of intervention was led by "Vemurafenib" (2 trials), "Atezolizumab" (1 trials), "Atezolizumab Placebo" (1 trials), "Cobimetinib" (1 trials) and "Vemurafenib Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitätsklinikum Regensburg; Klinik und Poliklinik für Dermatologie" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Universitätsklinikum Regensburg; Klinik und Poliklinik für Dermatologie". undefined are not yet recruiting, undefined are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Universitätsklinikum Regensburg; Klinik und Poliklinik für Dermatologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitätsklinikum Regensburg; Klinik und Poliklinik für Dermatologie, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 2 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".